Syntheses of aza and fluorine-substituted 3-(piperidin-4-y1)-4,5-dihydro-1H-benzo[d][1,3]diazepin-2(3H)-ones

被引:23
作者
Han, Xiaojun [1 ]
Civiello, Rita L. [1 ]
Mercer, Stephen E. [1 ]
Macor, John E. [1 ]
Dubowchik, Gene M. [1 ]
机构
[1] Bristol Myers Squibb Co, Res & Dev, Neurosci Discovery Chem, Wallingford, CT 06492 USA
关键词
CROSS-COUPLING REACTIONS; MEDICINAL CHEMISTRY; RECEPTOR ANTAGONISTS; ARYL CHLORIDES; DESIGN; 2,3-DIHYDROINDOLES; INHIBITORS; DISCOVERY; MIGRAINE; CATALYST;
D O I
10.1016/j.tetlet.2008.11.012
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A practical and expedient synthesis of the title compounds is described. They were prepared by Stille reaction of nitro halopyridines 4 or nitro fluro-halobenzenes 10, followed by Michael addition of tertbutyl 4-aminopiperidine-1-carboxylate to the resulting activated vinyl compounds 5 and 11, hydrogenation (-NO(2)->-NH(2)), cyclic urea formation, Boc removal, and HCl salt formation. However, N3 and F1 analogs could not be made by this general strategy. Activated vinyl compounds 5a and 5d when reacted with tert-butyl 4-aminopiperidine-1-carboxylate did not stop at the desired Michael addition stage; but proceeded to produce azaindolines 8 and 9. Michael addition did not occur to compound 11d; instead, the fluorine atom was displaced. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:386 / 388
页数:3
相关论文
共 29 条
[1]   Regulation of saccharide binding with basic poly(ethynylpyridine)s by H+-induced helix formation [J].
Abe, H ;
Masuda, N ;
Waki, M ;
Inouye, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (46) :16189-16196
[2]  
[Anonymous], 2005, [No title captured], Patent No. [WO 2005/013894, 2005013894]
[3]  
Beller M, 1998, ANGEW CHEM INT EDIT, V37, P3389, DOI 10.1002/(SICI)1521-3773(19981231)37:24<3389::AID-ANIE3389>3.0.CO
[4]  
2-D
[5]   Synthesis of 2,3-dihydroindoles, indoles, and anilines by transition metal-free amination of aryl chlorides [J].
Beller, M ;
Breindl, C ;
Riermeier, TH ;
Tillack, A .
JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (04) :1403-1412
[6]   Fluorine in medicinal chemistry [J].
Böhm, HJ ;
Banner, D ;
Bendels, S ;
Kansy, M ;
Kuhn, B ;
Müller, K ;
Obst-Sander, U ;
Stahl, M .
CHEMBIOCHEM, 2004, 5 (05) :637-643
[8]   Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors [J].
Gustin, DJ ;
Sehon, CA ;
Wei, JM ;
Cai, H ;
Meduna, SP ;
Khatuya, H ;
Sun, SQ ;
Gu, Y ;
Jiang, W ;
Thurmond, RL ;
Karlsson, L ;
Edwards, JP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) :1687-1691
[9]   An orally active corticotropin releasing factor 1 receptor antagonist from 8-aryl-1,3a,7,8-tetrazza-cyclopenta[a]indenes [J].
Han, Xiaojun ;
Civiello, Rita ;
Pin, Sokhom S. ;
Burris, Kevin ;
Balanda, Lynn A. ;
Knipe, Jay ;
Ren, Shelly ;
Fiedler, Tracey ;
Browman, Kaitlin E. ;
Maccl, Robert ;
Taber, Matthew T. ;
Zhang, Jie ;
Dubowchik, Gene M. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) :2026-2030
[10]   Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists [J].
Han, XJ ;
Pin, SS ;
Burris, K ;
Fung, LK ;
Huang, S ;
Taber, MT ;
Zhang, J ;
Dubowchik, GM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (18) :4029-4032